Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies
1.
Alanay A, Acaroglu E, Ozdemir O, Ercelen O, Bulutcu E,
Surat A: Effects of deamino-8-D-arginin vasopressin on blood loss and
coagulation factors in scoliosis surgery. A double-blind randomized clinical
trial. Spine 1999; 24:877-882
2.
Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff
H, Uretzky G, Pettersson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A: Analyses
of coronary graft patency after aprotinin use: results from the International
Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac
Cardiovasc Surg 1998; 116:716-730
3.
Almeida MF: Preoperative normovolemic hemodilution in
aesthetic plastic surgery. Aesthetic Plast Surg 1999; 23:445-449
4.
Alvarez JM, Jackson LR, Chatwin C, Smolich JJ: Low-dose
postoperative aprotinin reduces mediastinal drainage and blood product use in
patients undergoing primary coronary artery bypass grafting who are taking
aspirin: a prospective, randomized, double-blind, placebo-controlled trial. J
Thorac Cardiovasc Surg 2001; 122:457-463
5.
Alvarez JM, Quiney NF, McMillan D, Joscelyne K,
Connelly T, Brady P, Deal C, Wilson R: The use of ultra-low-dose aprotinin to
reduce blood loss in cardiac surgery. J Cardiothorac Vasc Anesth 1995; 9:29-33
6.
Amar D, Grant FM, Zhang H, Boland PJ, Leung DH, Healey
JA: Antifibrinolytic therapy and perioperative blood loss in cancer patients
undergoing major orthopedic surgery. Anesthesiology 2003; 98:337-342
7.
Andrews CM, Lane DW, Bradley JG: Iron pre-load for
major joint replacement. Transfus Med 1997; 7:281-286
8.
Armellin G, Sorbara C, Bonato R, Pittarello D, Cero PD,
Giron G: Intraoperative plasmapheresis in cardiac surgery. J Cardiothorac Vasc
Anesth 1997; 11:13-17
9.
Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson
A: Greater increase in cytokine concentration after salvage with filtered whole
blood than with washed red cells, but no difference in postoperative hemoglobin
recovery. Transfusion 1999; 39:271-276
10.
Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson
A: Postoperative inflammatory response after autologous and allogeneic blood
transfusion. Anesthesiology 1997; 87:511-516
11.
Avall A, Hyllner M, Swolin B, Bengtson J, Carlsson L,
Bengtsson A: Increased serum erythropoietin concentration after allogeneic
compared with autologous blood transfusion. Transfus Apheresis Sci 2002;
27:203-210
12.
Axford TC, Dearani JA, Ragno G, MacGregor H, Patel MA,
Valeri CR, Khuri SF: Safety and therapeutic effectiveness of reinfused shed
blood after open heart surgery. Ann Thorac Surg 1994; 57:615-622
13.
Bacher A, Mayer N, Rajek AM, Haider W: Acute
normovolaemic haemodilution does not aggravate gastric mucosal acidosis during
cardiac surgery. Intensive Care Med 1998; 24:313-321
14.
Bailey CR, Kelleher AA,
15.
Barnette RE, Wendling WW, Schweiger JW, Brister NW,
Schartel SA, Chen D,
16.
Bartels C, Bechtel JV, Winkler C, Horsch S:
Intraoperative autotransfusion in aortic surgery: comparison of whole blood
autotransfusion versus cell separation. J Vasc Surg 1996; 24:102-108
17.
Bartels C, Claeys L, Ktenidis K, Nigbur H, Horsch S:
Intraoperative whole blood autotransfusion during venous thrombectomy. J
Cardiovasc Surg 1994; 35:109-114
18.
Basora M, Gomar C, Escolar G, Pacheco M, Fita G,
Rodriguez E, Ordinas A: Platelet function during cardiac surgery and
cardiopulmonary bypass with low-dose aprotinin. J Cardiothorac Vasc Anesth
1999; 13:382-387
19.
Beath SM, Nuttall GA, Fass DN, Oliver WC Jr, Ereth MH,
Oyen LJ: Plasma aprotinin concentrations during cardiac surgery: full- versus
half-dose regimens. Anesth Analg 2000; 91:257-264
20.
Bedirhan MA, Turna A, Yagan N, Tasci O: Aprotinin
reduces postoperative bleeding and the need for blood products in thoracic
surgery: results of a randomized double-blind study. Eur J Cardiothorac Surg
2001; 20:1122-1127
21.
Benli IT, Akalin S, Duman E, Citak M, Kis M: The
results of intraoperative autotransfusion in orthopaedic surgery. Bull Hosp Jt
Dis 1999; 58:184-187
22.
Bennett SR: Perioperative autologous blood transfusion
in elective total hip prosthesis operations. Ann R Coll Surg Engl 1994;
76:95-98
23.
Bennett-Guerrero E, Sorohan JG, Canada AT, Ayuso L,
Newman MF, Reves JG, Mythen MG: e-aminocaproic acid plasma levels during cardiopulmonary
bypass. Anesth Analg 1997; 85:248-251
24.
Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P:
Predictive factors for perioperative blood transfusions in rectal resection for
cancer: A multivariate analysis of a group of 212 patients. Surgery 2001;
129:433-439
25.
Benoni G, Fredin H: Fibrinolytic inhibition with
tranexamic acid reduces blood loss and blood transfusion after knee
arthroplasty: a prospective, randomised, double-blind study of 86 patients. J
Bone Joint Surg Br 1996; 78:434-440
26.
Benoni G, Lethagen S, Nilsson P, Fredin H: Tranexamic
acid, given at the end of the operation, does not reduce postoperative blood
loss in hip arthroplasty. Acta Orthop Scand 2000; 71:250-254
27.
Biesma DH, Marx JJ, Kraaijenhagen RJ, Franke W,
Messinger D, van de Wiel A: Lower homologous blood requirement in autologous
blood donors after treatment with recombinant human erythropoietin. Lancet
1994; 344:367-370
28.
Billote DB, Glisson SN, Green D, Wixson RL: Efficacy of
preoperative autologous blood donation: analysis of blood loss and transfusion
practice in total hip replacement. J Clin Anesth 2000; 12:537-542
29.
Bjessmo S, Ivert T: Blood loss after coronary artery
bypass surgery: relations to patient variables and antithrombotic treatment.
Scand Cardiovasc J 2000; 34:438-445
30.
Blais RE, Hadjipavlou AG, Shulman G: Efficacy of
autotransfusion in spine surgery: comparison of autotransfusion alone and with
hemodilution and apheresis. Spine 1996; 21:2795-2800
31.
Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath
P, Lundsgaard-Hansen P: Comparison of the effects of aprotinin and tranexamic
acid on blood loss and related variables after?
cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108:1083-1091
32.
Body SC, Birmingham J, Parks R, Ley C, Maddi R, Shernan
SK, Siegel LC, Stover EP, D'Ambra MN, Levin J, Mangano DT, Spiess BD: Safety
and efficacy of shed mediastinal blood transfusion after cardiac surgery: a
multicenter observational study. Multicenter Study of Perioperative Ischemia
Research Group. J Cardiothorac Vasc Anesth 1999; 13:410-416
33.
Boldt J, Weber A, Mailer K, Papsdorf M, Schuster P:
Acute normovolaemic haemodilution vs controlled hypotension for reducing the
use of allogeneic blood in patients undergoing radical prostatectomy. Br J
Anaesth 1999; 82:170-174
34.
Bottner F, Pavone V, Johnson T, Heitkemper S, Sculco
TP: Blood management after bilateral total knee arthroplasty. Clin Orthop 2003;
410:254-261
35.
Boyer-Neumann C, Dreyfus M, Wolf M, Veyradier A, Meyer
D: Multi-therapeutic approach to manage delivery in an alloimmunized patient
with type 3 von Willebrand disease. J Thromb Haemost 2003; 1:190-192
36.
Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD,
Nierenberg H, Roger SL, Glynn MF: Tranexamic acid reduces blood loss,
transfusion requirements, and coagulation factor use in primary orthotopic
liver transplantation. Anesthesiology 1996; 85:1043-1048
37.
Braga M, Gianotti L, Vignali A, Gentilini O, Servida P,
Bordignon C, Di Carlo V: Evaluation of recombinant human erythropoietin to
facilitate autologous blood donation before surgery in anaemic patients with
cancer of the gastrointestinal tract. Br J Surg 1995; 82:1637-1640
38.
Brener SJ, Bhatt DL, Moliterno DJ, Schneider JP, Ellis
SG, Topol EJ: Revisiting optimal anticoagulation with unfractionated heparin
during coronary stent implantation. Am J Cardiol 2003; 92:1468-1471
39.
Brown RS, Thwaites BK, Mongan PD: Tranexamic acid is
effective in decreasing postoperative bleeding and transfusions in primary
coronary artery bypass operations: a double-blind, randomized,
placebo-controlled trial. Anesth Analg 1997; 85:963-970
40.
Burman JF, Westlake AS, Davidson SJ, Rutherford LC,
Rayner AS, Wright AM, Morgan CJ, Pepper JR: Study of five cell salvage machines
in coronary artery surgery. Transfus Med 2002; 12:173-179
41.
Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Chuljian
P, Busque S, Concepcion W, So SK, Esquivel CO: Primary liver transplantation
without transfusion of red blood cells. Surgery 1996; 120:698-704
42.
Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA:
The predictive value of modified computerized thromboelastography and platelet
function analysis for postoperative blood loss in routine cardiac surgery.
Anesth Analg 2003; 96:51-57
43.
Canver CC, Kroncke GM, Nichols RD, Murray EL, Mentzer
RM Jr: The effects of intraoperative autologous whole blood sequestration on
the need for transfusion of allogenic blood and blood products in coronary
bypass operations. J Cardiovasc Surg (Torino) 1995; 36:423-438
44.
Capdevila X, Calvet Y, Biboulet P, Biron C, Rubenovitch
J, d'Athis F: Aprotinin decreases blood loss and homologous transfusions in
patients undergoing major orthopedic surgery. Anesthesiology 1998; 88:50-57
45.
Casas JI, Zuazu-Jausoro I, Mateo J, Oliver A, Litvan H,
Muniz-Diaz E, Aris A, Caralps JM, Fontcuberta J: Aprotinin versus desmopressin
for patients undergoing operations with cardiopulmonary bypass. A double-blind
placebo-controlled study. J Thorac Cardiovasc Surg 1995; 110:1107-1117
46.
Casati V, Bellotti F, Gerli C, Franco A, Oppizzi M,
Cossolini M, Calori G, Benussi S, Alfieri O, Torri G: Tranexamic acid
administration after cardiac surgery: A prospective, randomized, double-blind,
placebo-controlled study. Anesthesiology 2001; 94:8-14
47.
Casati V, Gerli C, Franco A, Torri G, D'Angelo A,
Benussi S, Alfieri O: Tranexamic acid in off-pump coronary surgery: A preliminary,
randomized, double-blind, placebo-controlled study. Ann Thorac Surg 2001;
72:470-475
48.
Casati V, Speziali G, D'Alessandro C, Cianchi C,
Antonietta Grasso M, Spagnolo S, Sandrelli L: Intraoperative low-volume acute
normovolemic hemodilution in adult open-heart surgery. Anesthesiology 2002;
97:367-373
49.
Cash KL, Brown T, Sausais L, Uehlinger J, Reed LJ:
Severe delayed hemolytic transfusion reaction secondary to anti-At(a).
Transfusion 1999; 39:834-837
50.
Chan ACW, Blumgart LH, Wuest DL, Melendez JA, Fong Y:
Use of preoperative autologous blood donation in liver resections for
colorectal metastases. Am J Surg 1998; 175:461-465
51.
Chanda A, Smith DR, Nanda A: Autotransfusion by cell
saver technique in surgery of lumbar and thoracic spinal fusion with instrumentation.
J Neurosurg 2002; 96(3 Suppl):298-303
52.
Cheema P, El-Mefty O, Jazieh AR: Intraoperative
haemorrhage associated with the use of extract of Saw Palmetto herb: a case
report and review of the literaure. J Intern Med 2001; 250:167-169
53.
Chen L, Bracey AW, Radobancevic R, Cooper JR, Collard
CD, Vaughn WK, Nussmeier NA: Clopidogrel and bleeding in patients undergoing
elective coronary artery bypass grafting. J Thoracic Cardiovasc Surg 2004,
128:425-431
54.
Chikada M, Furuse A, Kotsuka Y, Yagyu K: Open-heart
surgery in Jehovah's Witness patients. Cardiovasc Surg 1996; 4:311-314
55.
Cicek S, Demirkilic U, Kuralay E, Ozal E, Tatar H:
Postoperative aprotinin: effect on blood loss and transfusion requirements in
cardiac operations. Ann Thorac Surg 1996; 61:1372-1376
56.
Cicek S, Demirkilic U, Ozal E, Kuralay E, Bingol H,
Tatar H, Ozturk OY: Postoperative use of aprotinin in cardiac operations: an
alternative to its prophylactic use. J Thorac Cardiovasc Surg 1996;
112:1462-1467
57.
Cina CS, Bruin G: Acute normovolemic hemodilution (ANH)
in surgery of the thoraco-abdominal aorta. A cohort study to evaluate
coagulation parameters and blood products utilization. J Cardiovasc Surg 1999;
40:37-43
58.
Cina CS, It SC, Clase CM, Bruin G: A cohort study of
coagulation parameters and the use of blood products in surgery of the thoracic
and thoracoabdominal aorta. J Vasc Surg 2001; 33:462-468
59.
Clagett GP, Valentine RJ, Jackson MR, Mathison C,
Kakish HB, Bengtson TD: A randomized trial of intraoperative autotransfusion
during aortic surgery. J Vasc Surg 1999; 29:22-30
60.
Clagett GP, Valentine RJ, Myers SI, Chervu A, Heller J:
Does desmopressin improve hemostasis and reduce blood loss from aortic surgery?
A randomized, double-blind study. J Vasc Surg 1995; 22:223-229
61.
Clugston PA, Fitzpatrick DG, Kester DA, Folet B,
Germann E: Autologous blood use in reduction mammaplasty: is it justified?
Plast Reconstr Surg 1995; 95:824-828
62.
Codispoti M, Mankad PS: Significant merits of a fibrin
sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised
controlled trial. Eur J Cardiothorac Surg 2002; 22:200-205
63.
Coffey A, Pittmam J, Halbrook H, Fehrenbacher J,
Beckman D, Hormuth D: The use of tranexamic acid to reduce postoperative
bleeding following cardiac surgery: a double-blind randomized trial. Am Surg
1995; 61:566-568
64.
Connelly NR, Kiessling BM, Brull SJ: Does tranexamic
acid decrease bleeding in patients undergoing cardiopulmonary bypass? Yale J
Biol Med 1994; 67:265-268
65.
Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K,
Buller RE: Intraoperative autologous blood collection and autotransfusion in
the surgical management of early cancers of the uterine cervix. Obstet Gynecol
1995; 86:373-378
66.
Consten ECJ, Henny CP, Eijsman L, Dongelmans DA, van
Oers MHJ: The routine use of fresh frozen plasma in operations with
cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg 1996;
112:162-167
67.
Copley LA, Richards BS, Safavi FZ, Newton PO:
Hemodilution as a method to reduce transfusion requirements in adolescent spine
fusion surgery. Spine 1999; 24:219-222
68.
Daily PO, Lamphere JA, Dembitsky WP, Adamson RM, Dans
NF: Effect of prophylactic epsilon-aminocaproic acid on blood loss and
transfusion requirements in patients undergoing first-time coronary artery
bypass grafting. A randomized, prospective, double-blind study. J Thorac
Cardiovasc Surg 1994; 108:99-106
69.
Dalmau A, Sabate A, Acosta F, Garcia-Huete L, Koo M,
Reche M, Rafecas A, Figueras J, Jaurrieta E: Comparative study of
antifibrinolytic drugs in orthotopic liver transplantation. Transplant Proc
1999; 31:2361-2362
70.
Dalmau A, Sabate A, Acosta F, Garcia-Huete L, Koo M,
Sansano T, Rafecas A, Figueras J, Jaurrieta E, Parrilla P: Tranexamic acid
reduces red cell transfusion better than epsilon-aminocaproic acid or placebo
in liver transplantation. Anesth Analg 2000; 91:29-34
71.
Dalrymple-Hay MJ, Pack L, Deakin CD, Shephard S, Ohri
SK, Haw MP, Livesey SA, Monro JL: Autotransfusion of washed shed mediastinal
fluid decreases the requirement for autologous blood transfusion following
cardiac surgery: a prospective randomized trial. Eur J Cardiothorac Surg 1999;
15:830-834
72.
D'Ambra MN, Akins CW, Blackstone EH, Bonney SL, Cohn
LH, Cosgrove DM, Levy JH, Lynch KE, Maddi R: Aprotinin in primary valve
replacement and reconstruction: a multicenter, double-blind, placebo-controlled
trial. J Thorac Cardiovasc Surg 1996; 112:1081-1089
73.
Dave SP, Greenstein AJ, Sachar DB, Harpaz N, Aledort L:
Bleeding diathesis in amyloidosis with renal insufficiency associated with
Crohn's disease: response to desmopressin. Am J Gastroenterol 2002; 97:187-189
74.
de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M,
Young DC: Baseline hemoglobin as a predictor of risk of transfusion and
response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996;
25:533-542
75.
de Pree C, Mermillod B, Hoffmeyer P, Beris P:
Recombinant human erythropoietin as adjuvant treatment for autologous blood
donation in elective surgery with large blood needs (> 5 units): a
randomized study. Transfusion 1997; 37:708-714
76.
del Pozo Pozo AI, Jimenez-Yuste V, Villar A, Quintana
M, Hernandez-Navarro F: Successful thyroidectomy in a patient with
Hermansky-Pudlak syndrome treated with recombinant activated factor VII and
platelet concentrates. Blood Coagul Fibrinolysis 2002; 13:551-553
77.
Despotis GJ, Levine V, Filos KS, Santoro SA, Joist JH,
Spitznagel E, Goodnough LT: Evaluation of a new point-of-care test that
measures PAF-mediated acceleration of coagulation in cardiac surgical patients.
Anesthesiology 1996; 85:1311-1323
78.
Despotis GJ, Levine V, Saleem R, Spitznagel E, Joist
JH: Use of point-of-care test in identification of patients who can benefit
from desmopressin during cardiac surgery: a randomised controlled trial. Lancet
1999; 354:106-110
79.
Dich-Nielsen JO, Rajan RM, Jensen JJ: An
anaphylactoid-like reaction following infusion of salvaged unwashed drain
blood. Can J Anaesth 1998; 45:189
80.
Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL,
Richter JA: Influence of high-dose aprotinin on anticoagulation, heparin
requirement, and celite- and kaolin-activated clotting time in
heparin-pretreated patients undergoing open-heart surgery. A double-blind,
placebo-controlled study. Anesthesiology 1995; 83:679-689
81.
Dignan RJ, Law DW, Seah PW, Manganas CW, Newman DC,
Grant PW, Wolfenden HD: Ultra-low dose aprotinin decreases transfusion
requirements and is cost effective in coronary operations. Ann Thorac Surg
2001; 71:158-63
82.
Dryden PJ, O'Connor JP, Jamieson WR, Reid I, Ansley D,
Sadeghi H, Burr LH, Munro AI, Merrick PM: Tranexamic acid reduces blood loss
and transfusion in reoperative cardiac surgery. Can J Anaesth 1997; 44:934-941
83.
Ehrlich M, Grabenwoger M, Cartes-Zumelzu F, Luckner D,
Kovarik J, Laufer G, Kocher A, Konetschny R, Wolner E, Havel M: Operations on
the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe? J
Thorac Cardiovasc Surg 1998; 115:220-225
84.
Ekback G, Axelsson K, Ryttberg L, Edlund B, Kjellberg
J, Weckstrom J, Carlsson O, Schott U: Tranexamic acid reduces blood loss in
total hip replacement surgery. Anesth Analg 2000; 91:1124-1130
85.
Ekback G, Schott U, Axelsson K, Carlberg M:
Perioperative autotransfusion and functional coagulation analysis in total hip
replacement. Acta Anaesthes Scand 1995; 39:390-395
86.
Engel JM, Hohaus T, Ruwoldt R, Menges T, Jurgensen I,
Hempelmann G: Regional hemostatic status and blood requirements after total
knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg
2001; 92:775-780
87.
Englberger L, Markart P, Eckstein FS, Immer FF, Berdat
PA, Carrel TP: Aprotinin reduces blood loss in off-pump coronary artery bypass
(OPCAB) surgery. Eur J Cardiothorac Surg 2002; 22:545-551
88.
Engstrom KG, Appelblad M, Brorsson, B: Mechanisms
behind operating room blood transfusions in coronary artery bypass graft
surgery patients with insignificant bleeding.?
J Cardiothorac Vasc Anes 2002; 16:539-544
89.
Ereth MH, Nuttall GA, Klindworth JT, MacVeigh I,
Santrach PJ, Orszulak TA, Harmsen WS, Oliver W Jr: Does the platelet-activated
clotting test (Hemo-STATUS) predict blood loss and platelet dysfunction
associated with cardiopulmonary bypass? Anesth Analg 1997; 85:257-264
90.
Ereth MH, Nuttall GA, Santrach PJ, Klindworth JT,
Oliver WC Jr, Schaff HV: The relation between the platelet-activated clotting
test (HemoSTATUS) and blood loss after cardiopulmonary bypass. Anesthesiology
1998; 88:962-969
91.
Estella NM, Berry DL, Baker BW, Wali AT, Belfort MA:
Normovolemic hemodilution before cesarean hysterectomy for placenta percreta.
Obstet Gynecol 1997; 90:669-670
92.
Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S,
Snider C, Fink A, Brook R: The cost effectiveness of preoperative autologous
blood donations. N Engl J Med 1995; 332:719-724
93.
Faris PM, Ritter MA, Abels RI: The effects of
recombinant human erythropoietin on perioperative transfusion requirements in
patients having a major orthopaedic operation. The American Erythropoietin
Study Group. J Bone Joint Surg Am 1996; 78:62-72
94.
Farrer A, Spark JI, Scott DJ: Autologous blood
transfusion: the benefits to the patients undergoing abdominal aortic aneurysm
repair. J Vasc Nurs 1997; 15:111-115
95.
Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC,
Whitsitt P, Wheeler SL, Lau CY: Erythropoietin with iron supplementation to
prevent allogeneic blood transfusion in total hip joint arthroplasty. A
randomized, controlled trial. Ann Intern Med 2000; 133:845-854
96.
Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer
RM Jr: Aspirin and postoperative bleeding after coronary artery bypass
grafting. Ann Surg 2002; 235:820-827
97.
Ferraz-Neto BH, Silva ED, Afonso RC, Gregory FH,
Meira-Filho SP, Macedo CP, Parra OM, Leitao RM, Saad WA: Acute normovolemic
intraoperative hemodilution in liver transplantation. Transplant Proc 1999;
31:3069-3070
98.
Findlay JY, Rettke SR, Ereth MH, Plevak DJ, Krom RA,
Kufner RP: Aprotinin reduces red blood cell transfusion in orthotopic liver
transplantation: a prospective, randomized, double-blind study. Liver Transpl
2001; 7:802-807
99.
Fitzsimmons MG, Peterfreund RA, Raines DE: Aprotinin
administration and pulmonary thromboembolism during orthotopic liver
transplantation: report of two cases. Anesth Analg 2001; 92:1418-1421
100. Florentino-Pineda
I, Blakemore LC, Thompson GH, Poe-Kochert C, Adler P, Tripi P: The Effect of e-aminocaproic
acid on perioperative blood loss in patients with idiopathic scoliosis
undergoing posterior spinal fusion: a preliminary prospective study. Spine
2001; 26:1147-1151
101. Ford
SM, Unsworth-White MJ, Aziz T, Tooze JA, van Besouw JP, Bevan DH, Treasure T:
Platelet pheresis is not a useful adjunct to blood-sparing strategies in
cardiac surgery. J Cardiothorac Vasc Anesth 2002; 16:321-329
102. Fox
JS, Amaranath L, Hoeltge GA, Andrish JT: Autologous blood transfusion and
intraoperative cell salvage in a patient with homozygous sickle cell disease.
Cleve Clin J Med 1994; 61:137-140
103. Franchini
M, de Gironcoli M, Lippi G, Manzato F, Aprili G, Gandini G: Prophylactic use of
desmopressin in surgery of six patients with symptomatic heterozygous factor XI
deficiency. Haematologica 2000; 85:106-107
104. Friederich
PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, Buller HR, Levi M:
Effect of recombinant activated factor VII on perioperative blood loss in
patients undergoing retropubic prostatectomy: a double-blind placebo-controlled
randomised trial. Lancet. 2003; 361:201-205
105. Garcia
L, Sabate A, Domenech P, Martinez Brotons F, Drudis R, Jaurrieta E: Aprotinin
in orthotopic liver transplantation. Transplant Proc 1995; 27:2290-2291
106. Garcia-Huete
L, Domenech P, Sabate A, Martinez-Brotons F, Jaurrieta E, Figueras J: The
prophylactic effect of aprotinin on intraoperative bleeding in liver
transplantation: a randomized clinical study. Hepatology 1997; 26:1143-1148
107. Gardner
A, Gibbs N, Evans C, Bell R: Relative cost of autologous red cell salvage
versus allogeneic red cell transfusion during abdominal aortic aneurysm repair.
Anaesth Intensive Care 2000; 28:646-649
108. Gaudino
M, Luciani N, Piancone FL, Bruno P, Rossi M, Schiavello R, Possati G:
Perioperative management of a patient with Werlhof disease undergoing
myocardial revascularization. J Cardiovasc Surg (Torino) 1999; 40:227-228
109. Gelb
AB, Roth RI, Levin J, London MJ, Noall RA, Hauck WW, Cloutier M, Verrier E,
Mangano DT: Changes in blood coagulation during and following cardiopulmonary
bypass. Am J Clin Pathol 1996; 106:87-99
110. Gerrah
R, Shargal Y, Elami A: Impaired oxygenation and increased hemolysis after
cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase
deficiency. Ann Thorac Surg 2003; 76:523-527
111. Gilbert
JB, Malkowicz SB, Wein AJ: Cell saver and radical retropubic prostatectomy:
analysis of cost-effectiveness. Urology 1995; 46:542-544
112. Giurati
G, Zanetta G, Caspani L, Landon F, Pellegrino A, Baglioni S, Mangioni C:
Autologous blood transfusion in patients undergoing radical hysterectomy. Br J
Obstet Gynaecol 1995; 102:64-65
113. Glazier
DB, Ciocca RG, Gosin JS, Murphy DP, Graham AM: Elective aortic surgery with
minimal banked blood. Am Surg 1998; 64:171-174
114. Godet
G, Fleron MH, Vicaut E, Zubicki A, Bertrand M, Riou B, Kieffer E, Coriat P:
Risk factors for acute postoperative renal failure in thoracic or
thoracoabdominal aortic surgery: a prospective study. Anesth Analg 1997;
85:1227-1232
115. Goh
M, Kleer CG, Kielczewski P, Wojno KJ, Kim K, Oesterling JE: Autologous blood
donation prior to anatomical radical retropubic prostatectomy: is it necessary?
Urology 1997; 49:569-573
116. Goldstein
DJ, DeRosa CM, Mongero LB, Weinberg AD, Michler RE, Rose EA, Oz MC, Smith CR:
Safety and efficacy of aprotinin under conditions of deep hypothermia and
circulatory arrest. J Thorac Cardiovasc Surg 1995; 110:1615-1621
117. Goldstein
DJ, Oz MC, Smith CR, Friedlander JP, De Rosa CM, Mongero LB, Delphin E: Safety
of repeat aprotinin administration for LVAD recipients undergoing cardiac
transplantation. Ann Thorac Surg 1996; 61:692-695
118. Goldstein
DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, Smith CR,
Rose EA, Levin HR, Oz MC: Use of aprotinin in LVAD recipients reduces blood
loss, blood use, and perioperative mortality. Ann Thorac Surg 1995;
59:1063-1067
119. Gombotz
H, Gries M, Sipurzynski S, Fruhwald S, Rehak P: Preoperative treatment with
recombinant human erythropoietin or predeposit of autologous blood in women
undergoing primary hip replacement. Acta Anaesthesiol Scand 2000; 44:737-742
120. Good
L, Peterson E, Lisander B: Tranexamic acid decreases external blood loss but
not hidden blood loss in total knee replacement. Br J Anaesth 2003; 90:596-599
121. Goodnough
LT, Monk TG, Sicard G, Satterfield SA, Allen B, Anderson CB, Thompson RW, Flye
W, Martin K: Intraoperative salvage in patients undergoing elective abdominal
aortic aneurysm repair: an analysis of cost and benefit. J Vasc Surg 1996;
24:213-218
122. Goodnough
LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler
WR, Wissel M, Abels RI: A phase III trial of recombinant human erythropoietin
therapy in non-anemic orthopedic patients subjected to aggressive removal of
blood for autologous use: Dose, response, toxicity, and efficacy. Transfusion
1994; 34:66-71
123. Gravlee
GP, Arora S, Lavendar SW, Mills SA, Hudspeth AS, Cordell AR, James RL,
Brockschmidt JK, Stuart JJ: Predictive value of blood clotting tests in cardiac
surgical patients. Ann Thorac Surg 1994; 58:216-221
124. Gray
CL, Amling CL, Polston GR, Powell CR, Kane CJ: Intraoperative cell salvage in
radical retropubic prostatectomy. Urology 2001; 58:740-745
125. Grosvenor
D, Goyal V, Goodman S: Efficacy of postoperative blood salvage following total
hip arthroplasty in patients with and without deposited autologous units. J
Bone Joint Surg Am 2000; 82-A:951-954
126. Hallak
M, Sharon AS, Diukman R, Auslender R, Abramovici H: Supplementing iron
intravenously in pregnancy. A way to avoid blood transfusions. J Reprod Med
1997; 42:99-103
127. Hardy
JF, Belisle S, Dupont C, Harel F, Robitaille D, Roy M, Gagnon L: Prophylactic
tranexamic acid and epsilon-aminocaproic acid for primary myocardial
revascularization. Ann Thorac Surg 1998; 65:371-376
128. Harley
BJ, Beaupre LA, Jones CA, Cinats JG, Guenther CR: The effect of epsilon
aminocaproic acid on blood loss in patients who undergo primary total hip
replacement: a pilot study. Can J Surg 2002; 45:185-190
129. Havel
M, Grabenwoger F, Schneider J, Laufer G, Wollenek G, Owen A, Simon P,
Teufelsbauer H, Wolner E: Aprotinin does not decrease early graft patency after
coronary artery bypass grafting despite reducing postoperative bleeding and use
of donated blood. J Thorac Cardiovasc Surg 1994; 107:807-810
130. Hayashi
J, Kumon K, Takanashi S, Kawashima Y, Eguchi S, Takaku F, Yamamura H:
Subcutaneous administration of recombinant human erythropoietin before cardiac
surgery: a double-blind, multicenter trial in Japan. Transfusion 1994;
34:142-146
131. Hayes
A, Murphy DB, McCarroll M: The efficacy of single-dose aprotinin 2 million KIU
in reducing blood loss and its impact on the incidence of deep venous
thrombosis in patients undergoing total hip replacement surgery. J Clin Anesth
1996; 8:357-360
132. Haynes
SL, Torella F, Wong JC, Dalrymple K, James M, McCollum CN: Economic evaluation
of a randomized clinical trial of haemodilution with cell salvage in aortic
surgery. Br J Surg 2002; 89:731-736
133. Healy
Wl, Pfeifer BA, Kurtz SR, Johnson C, Johnson W, Johnston R, Sanders D, Karpman
R, Hallack GN, Valeri CR: Evaluation of autologous shed blood for
autotransfusion after orthopaedic surgery. Clin Orthop 1994; 299:53-59
134. Hedstrom
M, Flordal PA, Ahl T, Svensson J, Dalen N: Autologous blood in hip replacement.
No effect on blood loss but less increase of plasminogen activator inhibitor in
a randomized series of 80 patients. Acta Orthop Scand 1996; 67:317-320
135. Heiss
MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, Dieterich HJ, Eissner
HJ, Schildberg FW: Blood transfusion-modulated tumor recurrence: first results
of a randomized study of autologous versus allogeneic blood transfusion in
colorectal cancer surgery. J Clin Oncol 1994: 12:1859-1867
136. Heiss
MM, Tarabichi A, Delanoff C, Allgayer H, Jauch KW, Hernandez-Richter T, Mempel
W, Beck KG, Schildberg FW, Messmer K: Perisurgical erythropoietin application
in anemic patients with colorectal cancer: A double-blind randomized study.
Surgery 1996; 119:523-527
137. Helm
RE, Klemperer JD, Rosengart TK, Gold JP, Peterson P, DeBois W, Altorki NK, Lang
S, Thomas S, Isom OW, Krieger KH: Intraoperative autologous blood donation
preserves red cell mass but does not decrease postoperative bleeding. Ann
Thorac Surg 1996; 62:1431-1441
138. Hendrice
C, Schmartz D, Pradier O, Coron T, Kucharcezwski C, d'Hollander A, Capel P:
Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses
in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc
Anesth 1995; 9:245-249
139. Hendriks
HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, Hagenaars AJ,
Melsen T, Slooff MJ, van der Meer J: Reduced transfusion requirements by
recombinant factor VIIa in orthotopic liver transplantation: a pilot study.
Transplantation 2001;71:402-405
140. Hendriks
HG, van der Meer J, Klompmaker IJ, Choudhury N, Hagenaars JA, Porte RJ, de Kam
PJ, Slooff MJ, de Wolf JT: Blood loss in orthotopic liver transplantation: a
retrospective analysis of transfusion requirements and the effects of
autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul
Fibrinolysis 2000; 11:S87-S93
141. Herregods
L, Moerman A, Foubert L, Den Blauwen N, Mortier E, Poelaert J, Struys M:
Limited intentional normovolemic hemodilution: ST-segment changes and use of
homologous blood products in patients with left main coronary artery stenosis.
J Cardiothorac Vasc Anesth 1997; 11:18-23
142. Hiippala
S, Strid L, Wennerstrand M, Arvela V, Mantyla S, Ylinen J, Niemela H:
Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with
total knee arthroplasty. Br J Anaesth 1995; 74:534-537
143. Hiippala
ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemela HM, Mantyla SK, Kuisma RP,
Ylinen JE: Tranexamic acid radically decreases blood loss and transfusions
associated with total knee arthroplasty. Anesth Analg 1997; 84:839-844
144. Hirsch
J, Wendt T, Kuhly P, Schaffartzik W: Point-of-care testing: measurement of
coagulation. Anaesthesia 2001; 56:760-763
145. Hobisch-Hagen
P, Schobersberger W, Falkensammer J, Luz G, Innerhofer P, Frischhut B,
Puschendorf B, Mair J: No release of cardiac troponin I during major orthopedic
surgery after acute normovolemic hemodilution. Acta Anaesthesiol Scand 1998;
42:799-804
146. Hohn
L, Schweizer A, Licker M, Morel DR: Absence of beneficial effect of acute
normovolemic hemodilution combined with aprotinin on allogeneic blood
transfusion requirements in cardiac surgery. Anesthesiology 2002; 96:276-282
147. Holmes
JH 4th, Jones MF, Anderson RP, Knopes KD, Guyton SW, Hall RA: The use of
micro-dose aprotinin with continuous infusion in coronary artery bypass
surgery. J Cardiovasc Surg (Torino) 1999; 40:621-626
148. Horlocker
TT, Nuttall GA, Dekutoski MB, Bryant SC: The accuracy of coagulation tests
during spinal fusion and instrumentation. Anesth Analg 2001; 93:33-38
149. Huber
TS, Carlton LC, Irwin PB, Flug RR, Harward TR, Flynn TC, Seeger JM:
Intraoperative autologous transfusion during elective infrarenal aortic
reconstruction. J Surg Res 1997; 67:14-20
150. Husted
H, Blond L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P: Tranexamic acid
reduces blood loss and blood transfusions in primary total hip arthroplasty: a
prospective randomized double-blind study in 40 patients. Acta Orthop Scand
2003; 74:665-669
151. Hyllner
M, Avall A, Swolin B, Bengtson JP, Bengtsson A: Autologous blood transfusion in
radical hysterectomy with and without erythropoietin therapy. Obstet Gynecol
2002; 99:757-762
152. Ivert
T, Intonti M, Stain-Malmgren R, Dumitrescu A, Blomback M: Effects of aprotinin
during cardiopulmonary bypass in patients treated with acetylsalicylic acid.
Scand Cardiovasc J 1998; 32:289-295
153. Jansen
AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K: Use of tranexamic acid
for an effective blood conservation strategy after total knee arthroplasty. Br
J Anaesth 1999; 83:596-601
154. Janssens
M, Joris J, David J, Lemaire R, Lamy M: High dose aprotinin reduces blood loss
in patients undergoing total hip replacement surgery. Anesthesiology 1994;
80:23-29
155. Jeserschek
R, Clar H, Aigner C, Rehak P, Primus B, Windhager R: Reduction of blood loss
using high-dose aprotinin in major orthopaedic surgery: a prospective, double-blind,
randomised and placebo-controlled study. J Bone Joint Surg Br 2003; 85:174-177
156. Jewell
AE, Akowuah EF, Suvarna SK, Braidley P, Hopkinson D, Cooper G: A prospective
randomised comparison of cardiotomy suction and cell saver for recycling shed
blood during cardiac surgery. Eur J Cardiothorac Surg 2003; 23:633-636
157. Johnson
HD, Morgan MS, Utley JR, Leyand SA, Nguyen-Duy T, Crawley DM: Comparative
analysis of recovery of cardiopulmonary bypass residual blood: cell saver vs
hemoconcentrator. J Extra Corpor Technol 1994; 26:194-199
158. Johnson
LB, Plotkin JS, Kuo PC: Reduced transfusion requirements during major hepatic
resection with use of intraoperative isovolemic hemodilution. Am J Surg 1998;
176:608-611
159. Jordan
D, Delphin E, Rose E: Prophylactic epsilon-aminocaproic acid (EACA)
administration minimizes blood replacement therapy during cardiac surgery.
Anesth Analg 1995; 80:827-829
160. Kahraman
S, Altunkaya H, Celebioglu B, Kanbak M, Pasaoglu I, Erdem K: The effect of
acute normovolemic hemodilution on homologous blood requirements and total
estimated red blood cell volume lost. Acta Anaesthesiol Scand 1997; 41:614-617
161. Kajikawa
M, Nonami T, Kurokawa T, Hashimoto S, Harada A, Nakao A, Takagi H: Autologous
blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular
carcinoma: use of recombinant human erythropoietin. Surgery 1994; 115:727-734
162. Karck
M, Haverich A: Heart transplantation under coumarin therapy: friend or foe? Eur
J Anaesthesiol 1994; 11:475-479
163. Karnezis
TA, Stulberg SD, Wixson RL, Reilly P: The hemostatic effects of desmopressin on
patients who had total joint arthroplasty. A double-blind randomized trial. J
Bone Joint Surg Am 1994; 76:1545-1550
164. Karski
JM, Teasdale SJ, Norman P, Carroll J, VanKessel K, Wong P, Glynn MF: Prevention
of bleeding after cardiopulmonary bypass with high-dose tranexamic acid.
Double-blind, randomized clinical trial. J Thorac Cardiovasc Surg 1995;
110:835-842
165. Kaspar
M, Ramsay MA, Nguyen AT, Cogswell M, Hurst G, Ramsay KJ: Continuous small-dose
tranexamic acid reduces fibrinolysis but not transfusion requirements during
orthotopic liver transplantation. Anesth Analg 1997; 85:281-285
166. Kasper
SM, Elsner F, Hilgers D, Grond S, Rutt J: A retrospective study of the effects
of small-dose aprotinin on blood loss and transfusion needs during total hip
arthroplasty. Eur J Anaesthesiol 1998; 15:669-675
167. Kasper
SM, Giesecke T, Limpers P, Sabatowski R, Mehlhorn U, Diefenbach C: Failure of
autologous fresh frozen plasma to reduce blood loss and transfusion
requirements in coronary artery bypass surgery. Anesthesiology 2001; 95:81-86
168. Katsaros
D, Petricevic M, Snow NJ, Woodhall DD, Van Bergen R: Tranexamic acid reduces
postbypass blood use: a double-blinded, prospective, randomized study of 210
patients. Ann Thorac Surg 1996; 61:1131-1135
169. Katz
K, Tamary H, Lahav J, Soudry M, Cohen IJ: Increased operative bleeding during
orthopaedic surgery in patients with type I Gaucher disease and bone
involvement. Bull Hosp Jt Dis 1999; 58:188-190
170. Kaufmann
CR, Dwyer KM, Crews JD, Dols SJ, Trask AL: Usefulness of thrombelastography in
assessment of trauma patient coagulation. J Trauma 1997; 42:716-722
171. Kemper
RR, Menitove JE, Hanto DW: Cost analysis of intraoperative blood salvage during
orthotopic liver transplantation. Liver Transpl Surg 1997; 3:513-517
172. Kesten
S, de Hoyas A, Chaparro C, Westney G, Winton T, Maurer JR: Aprotinin reduces
blood loss in lung transplant recipients. Ann Thorac Surg 1995; 59:877-879
173. Kettelhack
C, Hones C, Messinger D, Schlag PM: Randomized multicentre trial of the influence
of recombinant human erythropoietin on intraoperative and postoperative
transfusion need in anaemic patients undergoing right hemicolectomy for
carcinoma. Br J Surg 1998; 85:63-67
174. Kettner
SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M:
Use of abciximab-modified thrombelastography in patients undergoing cardiac
surgery. Anesth Analg 1999; 89:580-584
175. Kilgore
ML, Pacifico AD: Shed mediastinal blood transfusion after cardiac operations: a
cost-effectiveness analysis. Ann Thorac Surg 1998; 65:1248-1254
176. Kjaergard
HK, Trumbull HR: Vivostat system autologous fibrin sealant: preliminary study
in elective coronary bypass grafting. Ann Thorac Surg 1998; 66:482-486
177. Klodell
CT, Richardson JD, Bergamini TM, Spain DA: Does cell-saver blood administration
and free hemoglobin load cause renal dysfunction? Am Surg 2001; 67:44-47
178. Kluger
R, Olive DJ, Stewart AB, Blyth CM: Epsilon-aminocaproic acid in coronary artery
bypass graft surgery: preincision or postheparin? Anesthesiology 2003;
99:1263-1269
179. Kochamba
GS, Pfeffer TA, Sintek CF, Khonsari S: Intraoperative autotransfusion reduces
blood loss after cardiopulmonary bypass. Ann Thorac Surg 1996; 61:900-903
180. Kohli
N, Mallipeddi PK, Neff JM, Sze EH, Roat TW: Routine hematocrit after elective
gynecologic surgery. Obstet Gynecol 2000; 95:847-850
181. Kosmadakis
N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM,
Androulakis G: Perioperative erythropoietin administration in patients with
gastrointestinal tract cancer: prospective randomized double-blind study. Ann
Surg 2003; 237:417-421
182. Kyriss
T, Wurst H, Friedel G, Jaki R, Toomes H: Reduced blood loss by aprotinin in
thoracic surgical operations associated with high risk of bleeding. A
placebo-controlled, randomized phase IV study. Eur J Cardiothorac Surg 2001;
20:38-41
183. Lab
M, Welz A, Kocks M, Mayer G, Schwandt M, Hannekum A.: Aprotinin in elective
primary bypass surgery: graft patency and clinical efficacy. Eur J Cardiothorac
Surg 1995; 9:206-210
184. Langdown
AJ, Field J, Grote J, Himayat H: Aprotinin (Trasylol) does not reduce bleeding
in primary total hip arthroplasty. J Arthroplasty 2000; 15:1009-1012
185. Laub
GW, Riebman JB, Chen C, Adkins MS, Anderson WA, Fernandez J, McGrath LB: The
impact of aprotinin on coronary artery bypass graft patency. Chest 1994;
106:1370-1375
186. Lazzara
RR, Kidwell FE, Kraemer MF, Wood JA, Starr A: Reduction in costs, blood
products, and operating time in patients undergoing open heart surgery. Arch
Surg 1997; 132:858-860
187. Le
Roux PD, Elliott JP, Winn HR: Blood transfusion during aneurysm surgery.
Neurosurgery 2001; 49:1068-1075
188. Lemmer
JH Jr, Dilling EW, Morton JR, Rich JB, Robicsek F, Bricker DL, Hantler CB,
Copeland JG 3rd, Ochsner JL, Daily PO, Whitten CW, Noon GP, Maddi R: Aprotinin
for primary coronary artery bypass grafting: a multicenter trial of three dose
regimens. Ann Thorac Surg 1996; 62:1659-1667
189. Lemmer
JH Jr, Metzdorff MT, Krause AH Jr, Martin MA, Okies JE, Hill JG: Emergency
coronary artery bypass graft surgery in abciximab-treated patients. Ann Thorac
Surg 2000; 69:90-95
190. Lemmer
JH Jr, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, Holt WW, Karp
RB, Laub GW, Lipton MJ, Schaff HV, Tatooles CJ, Rumberger JAl: Aprotinin for
coronary bypass operations: efficacy, safety, and influence on early saphenous
vein graft patency. A multicenter, randomized, double-blind, placebo-controlled
study. J Thorac Cardiovasc Surg 1994; 107:543-551
191. Lentschener
C, Benhamou D, Mercier FJ, Boyer-Neumann C, Naueau S, Smadja C, Wold M, Franco
D: Aprotinin reduces blood loss and transfusion requirement in patients
undergoing elective liver resection. Anesth Analg 1997; 84:875-881
192. Lentschener
C, Cottin P, Bouaziz H, Mercier FJ, Wolf M, Aljabi Y, Boyer-Neumann C, Benhamou
D: Reduction of blood loss and transfusion requirement by aprotinin in
posterior lumbar spine fusion. Anesth Analg 1999; 89:590-597
193. Levy
JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, Rosengart TK, Murray J,
Clark RE, Smith P, Nadel A, Bonney SL, Kleinfield R: A multicenter,
double-blind, placebo-controlled trial of aprotinin for reducing blood loss and
the requirement for donor-blood transfusion in patients undergoing repeat
coronary artery bypass grafting. Circulation 1995; 92:2236-2244
194. Levy
O, Martinowitz U, Oran A, Tauber C, Horoszowski H: The use of fibrin tissue
adhesive to reduce blood loss and the need for blood transfusion after total
knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint
Surg Am 1999; 81:1580-1588
195. Lindgren
L, Yli-Hankala A, Halme L, Koskimies S, Orko R: Transfusion-related acute lung
injury (TRALI) after fresh frozen plasma in a patient with coagulopathy. Acta
Anaesthesiol Scand 1996; 40:641-644
196. Lisander
B, Jonsson R, Nordwall A: Combination of blood-saving methods decreases
homologous blood requirements in scoliosis surgery. Anaesth Intensive Care
1996; 24:555-558
197. Llamas
P, Cabrera R, Gomez-Arnau J, Fernandez MN: Hemostasis and blood requirements in
orthotopic liver transplantation with and without high-dose aprotinin.
Haematologica 1998; 83:338-346
198. Loubser
PG: Use of acute normovolemic hemodilution for blood conservation during
off-pump coronary artery bypass surgery. Can J Anaesth 2003; 50:620-621? Erratum in: Can J Anaesth. 2003
Aug-Sep;50(7):754
199. Mackay
Z, Shugufta Q, Din M, Guru AA: Hemodilution in complicated high velocity
vascular injuries of limbs. J Cardiovasc Surg 1996; 37:217-221
200. Makrydimas
G, Lolis D, Lialios G, Tsiara S, Georgiou I, Bourantas KL: Recombinant human
erythropoietin treatment of postpartum anemia. Preliminary results. Eur J
Obstet Gynecol Reprod Biol 1998; 81:27-31
201. Marcel
RJ, Stegall WC, Suit CT, Arnold JC, Vera RL, Ramsay MA, O'Donnell MB, Swygert
TH, Hein AT, Whitten CW: Continuous small dose aprotinin controls fibrinolysis
during orthotropic liver transplantation. Anesth Analg 1996; 82:1122-1125
202. Marty-Ane
CH, Alric P, Picot MC, Picard E, Colson P, Mary H: Ruptured abdominal aortic
aneurysm: influence of intraoperative management on surgical outcome. J Vasc
Surg 1995; 22:780-786
203. Matot
I, Scheinin O, Jurim O, Eid A: Effectiveness of acute normovolemic hemodilution
to minimize allogeneic blood transfusion in major liver resections.
Anesthesiology 2002; 97:794-800
204. McGill
N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R: Mechanical methods of
reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ
2002; 324:1299-303
205. Menges
T, Wagner RM, Welters I, Ruwoldt R, Boldt J, Hempelmann G: The role of protein
C-thrombomodulin system and fibrinolysis during cardiovascular surgery:
influence of acute preoperative plasmapheresis. J Cardiothorac Vasc Anesth
1996; 10:482-489
206. Menges
T, Welters I, Wagner RM, Boldt J, Dapper F, Hempelmann G: The influence of
acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood
loss and transfusion requirements in cardiac surgery. Eur J Cardiothorac Surg
1997; 11:557-563
207. Menichetti
A, Tritapepe L, Ruvolo G, Speziale G, Cogliati A, Di Giovanni C, Pacilli M,
Criniti A: Changes in coagulation patterns, blood loss and blood use after
cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic
acid. J Cardiovasc Surg 1996; 37:401-407
208. Mercuriali
F, Gualtieri G, Sinigaglia L, Inghilleri G, Biffi E, Vinci A, Colotti MT,
Barosi G, Lambertengh Deliliers G: Use of recombinant human erythropoietin to
assist autologous blood donation by anemic rheumatoid arthritis patients
undergoing major orthopedic surgery. Transfusion 1994; 34:501-506
209. Mercuriali
F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Oriani G: Epoetin alfa in low
hematocrit patients to facilitate autologous blood donation in total hip
replacement: a randomized, double-blind, placebo-controlled, dose-ranging
study. Acta Haematol 1998; 100:69-76
210. Molenaar
IQ, Legnani C, Groenland TH, Palareti G, Begliomini B, Terpstra OT, Porte RJ:
Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic,
but not a prothrombotic, effect. Liver Transpl 2001; 7:896-903
211. Mongan
PD, Brown RS, Thwaites BK: Tranexamic acid and aprotinin reduce postoperative
bleeding and transfusions during primary coronary revascularization. Anesth
Analg 1998; 87:258-265
212. Monte
S, Lyons G: Peripartum management of a patient with Glanzmann's thrombasthenia
using Thrombelastograph. Br J Anaesth 2002; 88:734-738
213. Mora
Mangano CT, Neville MJ, Hsu PH, Mignea I, King J, Miller DC: Aprotinin, blood
loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation
2001; 104:I276-1281
214. Moscardo
F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller
S, Sanz MA: Successful? treatment of
severe intra-abdominal bleeding associated with disseminated intravascular
coagulation using recombinant activated factor VII. Br J Haematol 2001;
114:174-176
215. Muller
U, Roder C, Pisan M, Orler R, El-Kerdi A, Eggli S: Autologous blood donation in
total knee arthroplasties is not necessary. Acta Orthop Scand 2004 ;75:66-70
216. Murkin
JM, Haig GM, Beer KJ, Cicutti N, McCutchen J, Comunale ME, Hall R, Ruzicka BB:
Aprotinin decreases exposure to allogeneic blood during primary unilateral
total hip replacement. J Bone Joint Surg Am 2000; 82:675-684
217. Murkin
JM, Lux J, Shannon NA, Guiraudon GM, Menkis AH, McKenzie FN, Novick RJ:
Aprotinin significantly decreases bleeding and transfusion requirements in
patients receiving aspirin and undergoing cardiac operations. J Thorac
Cardiovasc Surg 1994; 107:554-561
218. Murkin
JM, Shannon NA, Bourne RB, Rorabeck CH, Cruickshank M, Wyile G: Aprotinin
decreases blood loss in patients undergoing revision or bilateral total hip
artgroplasty. Anesth Analg 1995; 80:343-348
219. Murray
DJ, Pennell BJ, Weinstein SL, Olson JD: Packed red cells in acute blood loss:
Dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg 1995;
80:336-342
220. Myers
ER, Clarke-Pearson DL, Olt GJ, Soper JT, Berchuck A: Preoperative coagulation
testing on a gynecologic oncology service. Obstet Gynecol 1994; 83:438-444
221. Nash
J, Hodgson C, Desmond M, Russell GN, Jackson M: Routine use of a cell saver
during coronary artery by-pass grafting. Transfusion 1996; 36:657-658
222. Neilipovitz
DT, Murto K, Hall L, Barrowman NJ, Splinter WM: A randomized trial of tranexamic
acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 2001;
93:82-87
223. Nuttall
GA, Oliver WC, Beynen FM, Santrach PJ, Strickland RA, Murray MJ: Determination
of normal versus abnormal activated partial thromboplastin time and prothrombin
time after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1995; 9:355-361
224. Nuttall
GA, Oliver WC, Ereth MH, Santrach PJ, Bryant SC, Orszulak TA, Schaff HV:
Comparison of blood-conservation strategies in cardiac surgery patients at high
risk for bleeding. Anesthesiology 2000; 92:674-682
225. Nuttall
GA, Oliver WC, Ereth MH, Santrach PJ: Coagulation tests predict bleeding after
cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11:815-823
226. Oefelein
MG, Colangelo LA, Rademaker AW, McVary KT: Intraoperative blood loss and
prognosis in prostate cancer patients undergoing radical retropubic
prostatectomy. J Urol 1995; 154:442-447
227. O'Hara
PJ, Hertzer NR, Krajewski LP, Cox GS, Beven EG: Reduction in the homologous
blood requirement for abdominal aortic aneurysm repair by the use of
preadmission autologous blood donation. Surgery 1994; 115:69-76
228. Oliver
WC Jr, Santrach PJ, Danielson GK, Nuttall GA, Schroeder DR, Ereth MH:
Desmopressin does not reduce bleeding and transfusion requirements in
congenital heart operations. Ann Thorac Surg 2000; 70:1923-1930
229. Olsfanger
D, Fredman B, Goldstein B, Shapiro A, Jedeikin R: Acute normovolaemic
haemodilution decreases postoperative allogeneic blood transfusion after total
knee replacement. Br J Anaesth 1997; 79:317-321
230. Ozkisacik
E, Islamoglu F, Posacioglu H, Yagdi T, Basarir S, Omay SB, Ozbaran M, Buket S:
Desmopressin usage in elective cardiac surgery. J Cardiovasc Surg (Torino)
2001; 42:741-747
231. Pagani
FD, Polito RJ, Bolling SF: Mitral valve reconstruction in sickle cell disease.
Ann Thorac Surg 1996; 61:1841-1843
232. Palmer
JD, Francis DA, Roath OS, Francis JL, Iannotti F: Hyperfibrinolysis during
intracranial surgery: effect of high dose aprotinin. J Neurosurg Psychiatry
1995; 58:104-106
233. Palmer
JD, Francis JL, Pickard JD, Iannotti F: The efficacy and safety of aprotinin
for hemostasis during intracranial surgery. J Neurosurg 2003; 98:1208-1216
234. Parolari
A, Antona C, Alamanni F, Spirito R, Naliato M, Gerometta P, Arena V, Biglioli
P: Aprotinin and deep hypothermic circulatory arrest: there are no benefits
even when appropriate amounts of heparin are given. Eur J Cardiothorac Surg
1997; 11:149-156
235. Patrassi
GM, Viero M, Sartori MT, De Silvestro G, Rossaro L, Burra P, Nolli ML, Piccinni
P, Bassi N: Aprotinin efficacy on intraoperative bleeding and transfusion
requirements in orthotopic liver transplantation. Transfusion 1994; 34:507-511
236. Pellegrino
A, Landoni F, Cormio G, Ferrando P, Lissoni A, Scalambrino S, Mangioni C:
Effectiveness of autologous blood transfusion in patients undergoing radical
hysterectomy. Ann Chir Gynaecol 1995; 84:391-394
237. Penta
de Peppo A, Pierri MD, Scafuri A, De Paulis R, Colantuono G, Caprara E, Tomai
F, Chiariello L: Intraoperative antifibrinolysis and blood-saving techniques in
cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Tex Heart Inst
J 1995; 22:231-236
238. Pinkerton
PH, Covens A: Autologous blood transfusion in radical hysterectomy. Transfus
Med 1996; 6:223-225
239. Pirat
A, Sargin D, Torgay A, Arslan G: Identification of preoperative predictors of intraoperative
blood transfusion requirement in orthotopic liver transplantation. Transplant
Proc 2002; 34:2153-2155
240. Pleym
H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O: Single-dose tranexamic
acid reduces postoperative bleeding after coronary surgery in patients treated
with aspirin until surgery. Anesth Analg 2003; 96:923-928
241. Pleym
H, Stenseth R, Wahba A, Bjella L, Tromsdal A, Karevold A, Dale O: Prophylactic
treatment with desmopressin does not reduce postoperative bleeding after
coronary surgery in patients treated with aspirin before surgery. Anesth Analg
2004; 98:578-584
242. Porte
RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L,
Palareti G, Hermans J, Terpstra OT: Aprotinin and transfusion requirements in
orthotopic liver transplantation: a multicentre randomised double-blind study.
Lancet 2000; 355:1303-1309
243. Posacioglu
H, Apaydin AZ, Islamoglu F, Calkavur T, Yagdi T, Atay Y, Buket S: Adverse
effects of cell saver in patients undergoing ruptured abdominal aortic aneurysm
repair. Ann Vasc Surg 2002; 16:450-455
244. Potter
PS, Waters JH, Burger GA, Mraovic B: Application of cell-salvage during
cesarean section. Anesthesiology 1999; 90:619-621
245. Price
TH, Goodnough LT, Vogler W, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC,
Abels RI: The effect of recombinant human erythropoietin on the efficacy of
autologous blood donation in patients with low hematocrits: A multicenter,
randomized, double-blind controlled trial. Transfusion 1996; 36:29-36
246. Propst
JW, Siegel LC, Feeley TW: Effect of aprotinin on transfusion requirements
during repeat sternotomy for cardiac transplantation surgery. Transplant Proc
1994; 26:3719-3721
247. Pugh
SC, Wielogorski AK: A comparison of the effects of tranexamic acid and low-dose
aprotinin on blood loss and homologous blood usage in patients undergoing
cardiac surgery. J Cardiothorac Vasc Anesth 1995; 9:240-244
248. Qvist
N, Boesby S, Wolff B, Hansen CP: Recombinant human erythropoietin and
hemoglobin concentration at operation and during the postoperative period:
reduced need for blood transfusions in patients undergoing colorectal
surgery--prospective double-blind placebo-controlled study. World J Surg 1999;
23:30-35
249. Rainaldi
MP, Tazzari PL, Scagliarini G, Borghi B, Conte R: Blood salvage during
caesarean section. Br J Anaesth 1998; 80:195-198
250. Ramnath
AN, Naber HR, de Boer A, Leusink JA: No benefit of intraoperative whole blood
sequestration and autotransfusion during coronary artery bypass grafting:
results of a randomized clinical trial. J Thorac Cardiovasc Surg 2003; 125:1432-1437
251. Ranaboldo
CJ, Thompson JF, Davies JN, Shutt AM, Francis JN, Roath OS, Webster JH, Chant
AD: Prospective randomized placebo-controlled trial of aprotinin for elective
aortic reconstruction. Br J Surg 1997; 84:1110-1113
252. Rauh
MA, Bayers-Thering M, LaButti RS, Krackow KA: Preoperative administration of
epoetin alfa to total joint arthroplasty patients. Orthopedics 2002; 25:317-320
253. Ray
JG, Deniz S, Olivieri A, Pollex E, Vermeulen MJ, Alexander KS, Cain DJ,
Cybulsky I, Hamielec CM: Increased blood product use among coronary artery
bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovasc
Disord 2003; 3:3
254. Ray
MJ, Hales MM, Brown L, O'Brien MF, Stafford EG: Postoperatively administered
aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited
benefit. Ann Thorac Surg 2001; 72:521-526
255. Ray
MJ, Marsh NA, Just SJ, Perrin EJ, O'Brien MF, Hawson GA: Preoperative platelet
dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. Ann
Thorac Surg 1997; 63:57-63
256. Rebarber
A, Lonser R, Jackson S, Copel JA, Sipes S: The safety of intraoperative
autologous blood collection and autotransfusion during cesarean section. Am J
Obstet Gynecol 1998; 179:715-720
257. Reents
W, Babin-Ebell J, Misoph MR, Schwarzkopf A, Elert O: Influence of different
autotransfusion devices on the quality of salvaged blood. Ann Thorac Surg 1999;
68:58-62
258. Rehm
M, Orth V, Kreimeier U, Thiel M, Haller M, Brechtelsbauer H, Finsterer U:
Changes in intravascular volume during acute normovolemic hemodilution and
intraoperative retransfusion in patients with radical hysterectomy.
Anesthesiology 2000; 92:657-664
259. Reich
DL, Yanakakis MJ, Vela-Cantos FP, DePerio M, Jacobs E: Comparison of bedside
coagulation monitoring tests with standard laboratory tests in patients after
cardiac surgery. Anesth Analg 1999; 88:312-319
260. Riou
B, Arock M, Guerrero M, Ramos M, Thoreux P, Guillosson JJ, Roy-Camille R, Viars
P: Haematological effects of postoperative autotransfusion in spinal surgery.
Acta Anaesthesiol Scand 1994; 38:336-341
261. Roberts
WA, Kirkley SA, Newby M: A cost comparison of allogeneic and preoperatively or
intraoperatively donated autologous blood. Anesth Analg 1996; 83:129-133
262. Robinson
J, Nawaz S, Beard JD: Randomized, multicentre, double-blind, placebo-controlled
trial of the use of aprotinin in the repair of ruptured abdominal aortic
aneurysm. Br J Surg 2000; 87:754-757
263. Rocha
E, Hidalgo F, Llorens R, Melero JM, Arroyo JL, Paramo JA. Randomized study of
aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary
bypass surgery. Circulation 1994; 90:921-927
264. Rollo
VJ, Hozack WJ, Rothman RH, Chao W, Eng KO: Prospective randomized evaluation of
blood salvage techniques for primary total hip arthroplasty. J Arthroplasty
1995; 10:532-539
265. Rousou
JA, Engelman RM, Flack JE 3rd, Deaton DW, Owen SG: Tranexamic acid
significantly reduces blood loss associated with coronary revascularization.
Ann Thorac Surg 1995; 59:671-675
266. Rzyman
W, Dziadziuszko R, Skokowski J, Wilimski R, Raiter A, Szymanowska A, Jassem J: The
influence of blood transfusion on survival in operated non-small cell lung
cancer patients. J Thorac Cardiovasc Surg 2003; 126:755-760
267. Safwat
AM, Bush R, Prevec W, Reitan JA: Intraoperative use of platelet-plasmapheresis
in vascular surgery. J Clin Anesth 2002; 14:10-14
268. Samama
CM, Langeron O, Rosencher N, Capdevila X, Rouche P, Pegoix M, Berniere J,
Coriat P: Aprotinin versus placebo in major orthopedic surgery: a randomized,
double-blinded, dose-ranging study. Anesth Analg 2002; 95:287-293
269. Samama
CM, Quezada R, Riou B, Mourgeon E, Arock M, Ankri A, Viars P: Intraoperative
measurement of activated partial thromboplastin time and prothrombin time with
a new compact monitor. Acta Anaesth Scand 1994; 38:232-237
270. Sandrelli
L, Pardini A, Lorusso R, Sala ML, Licenziati M, Alfieri O: Impact of autologous
blood predonation on a comprehensive blood conservation program. Ann Thorac
Surg 1995; 59:730-755
271. Santamaria
A, Mateo J, Oliver A, Litvan H, Murillo J, Souto JC, Fontcuberta J: The effect
of two different doses of aprotinin on hemostasis in cardiopulmonary bypass
surgery: similar transfusion requirements and blood loss. Haematologica 2000;
85:1277-1284
272. Schmied
H, Schiferer A, Sessler DI, Meznik C: The effects of red-cell scavenging,
hemodilution, and active warming on allogenic blood requirements in patients
undergoing hip or knee arthroplasty. Anesth Analg 1998; 86:387-391
273. Scott
SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH: The effects of epoetin
alfa on transfusion requirements in head and neck cancer patients: a
prospective, randomized, placebo-controlled study. Laryngoscope 2002;
112:1221-1229
274. Scudamore
CH, Randall TE, Jewesson PJ, Shackleton CR, Salvian AJ, Fagan M, Frighetto L,
Growe GH, Scarth I, Erb SR: Aprotinin reduces the need for blood products
during liver transplantation. Am J Surg 1995; 169:546-549
275. Seigne
PW, Shorten GD, Johnson RG, Comunale ME: The effects of aprotinin on blood
product transfusion associated with thoracic aortic surgery requiring deep
hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 2000; 14:676-681
276. Serrano
FJ, Monux G, Aroca M: Should the cell saver autotransfusion system be routinely
used in elective aortic surgery? Ann Vasc Surg 2000; 14:663-668
277. Shapiro
GS, Boachie-Adjei O, Dhawlikar SH, Maier LS: The use of Epoetin alfa in complex
spine deformity surgery. Spine 2002; 27:2067-2071
278. Shenolikar
A, Wareham K, Newington D, Thomas D, Hughes J, Downes M: Cell salvage auto
transfusion in total knee replacement surgery. Transfus Med 1997; 7:277-280
279. Sheridan
DP, Card RT, Pinilla JC, Harding SM, Thomson DJ, Gauthier L, Drotar D: Use of
desmopressin acetate to reduce blood transfusion requirements during cardiac
surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. Can
J Surg 1994; 37:33-36
280. Shigeta
O, Kojima H, Jikuya T, Terada Y, Atsuni N, Sakakibara Y, Nagasawa T, Mitsui T:
Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary
bypass. Circulation 1997; 96:569-574
281. Shore-Lesserson
L, Reich DL, DePerio M, Silvay G: Autologous platelet-rich plasmapheresis: risk
versus benefit in repeat cardiac operations. Anesth Analg 1995; 81:229-235
282. Shore-Lesserson
L, Reich DL, Vela-Cantos F, Ammar T, Ergin MA: Tranexamic acid reduces
transfusions and mediastinal drainage in repeat cardiac surgery. Anesth Analg
1996; 83:18-26
283. Shulman
G, Grecula MJ, Hadjipavlou AG: Intraoperative autotransfusion in hip
arthroplasty. Clin Orthop 2002; 396:119-30
284. Shulman
G, Solanki DR, Hadjipavlou A: Augmented autologous transfusions in major
reconstructive spine surgery. J Clin Apheresis 1998; 13:62-68
285. Simonian
PT, Robinson RP: Titanium contamination of recycled Cell Saver blood in
revision hip arthroplasty. J Arthroplasty 1995; 10:83-86
286. Slappendel
R, Huvers FC, Benraad B, Novakova I, van Hellenmondt GG: Use of recombinant
factor VIIa to reduce postoperative bleeding after total hip arthroplasty in a
patient with cirrhosis and thrombocytopenia. Anesthesiology 2002; 96:1525-1527
287. Slaughter
TF, Faghih F, Greenberg CS, Leslie JB, Sladen RN: The effects of
epsilon-aminocaproic acid on fibrinolysis and thrombin generation during
cardiac surgery. Anesth Analg 1997; 85:1221-1226
288. Sokolic
V, Bukovic D, Fures R, Zadro M, Scuric I, Colak F, Celovec K, Bocan A:
Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after caesarean
section--a case report. Coll Antropol 2002; 26:155-157
289. Sowade
O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, Gross J: Avoidance of
allogeneic blood transfusions by treatment with epoetin beta (recombinant human
erythropoietin) in patients undergoing open-heart surgery. Blood 1997;
89:411-418
290. Sowade
O, Ziemer S, Sowade B, Franke W, Messinger D, Ziebell E, Scigalla P, Warnke H:
The effect of preoperative recombinant human erythropoietin therapy on
platelets and hemostasis in patients undergoing cardiac surgery. J Lab Clin Med
1997; 129:376-383
291. Spark
JI, Chetter IC, Kester RC, Scott DJ: Allogeneic versus autologous blood during
abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 1997; 14:482-486
292. Speekenbrink
RG, Wildevuur CR, Sturk A, Eijsman L: Low-dose and high-dose aprotinin improve
hemostasis in coronary operations. J Thorac Cardiovasc Surg 1996; 112:523-530
293. Spiess
BD, Gillies BSA, Chandler, W, Verrier E: Changes in transfusion therapy and
reexploration rate after institution of a blood management program in cardiac
surgical patients.? J Cardiothorac Vasc
Anesth 1995; 9:168-173
294. Stewart
A, Newman L, Sneddon K, Harris M: Aprotinin reduces blood loss and the need for
transfusion in orthognathic surgery. Br J Oral Maxillofac Surg 2001; 39:365-370
295. Stover
EP, Siegel LC, Hood PA, O'Riordan GE, McKenna TR: Platelet-rich plasma
sequestration, with therapeutic platelet yields, reduces allogeneic transfusion
in complex cardiac surgery. Anesth Analg 2000; 90:509-516
296. Stratmann
G, Russell IA, Merrick SH: Use of recombinant factor VIIa as a rescue treatment
for intractable bleeding following repeat aortic arch repair. Ann Thorac Surg
2003; 76:2094-2097
297. Sutton
SW, Hunley EK, Duncan MA, Rodriguez R, Meyers TP: Sickle cell disease and
aortic valve replacement: use of cardiopulmonary bypass, partial exchange
transfusion, platelet sequestration, and continuous hemofiltration. Tex Heart
Inst J 1999; 26:283-288
298. Swart
MJ, Gordon PC, Hayse-Gregson PB, Dyer RA, Swanepoel AL, Buckels NJ, Schall R,
Odell JA: High-dose aprotinin in cardiac surgery--a prospective, randomized
study. Anaesth Intensive Care 1994; 22:529-533
299. Szalay
D, Wong D, Lindsay T: Impact of red cell salvage on transfusion requirements
during elective abdominal aortic aneurysm repair. Ann Vasc Surg 1999;
13:576-581
300. Tabuchi
N, Njo TL, Tigchelaar I, Huyzen RJ, Boonstra PW, van Oeveren W: Monitoring of
anticoagulation in aprotinin-treated patients during heart operation. Ann
Thorac surg 1994; 58:774-777
301. Taggart
DP, Djapardy V, Naik M, Davies A: A randomized trial of aprotinin (Trasylol) on
blood loss, blood product requirement, and myocardial injury in total arterial
grafting. J Thorac Cardiovasc Surg 2003; 126:1087-1094
302. Tawes
RL Jr, Duvall TB: Is the "salvaged-cell syndrome" myth or reality? Am
J Surg 1996; 172:172-174
303. Temeck
BK, Bachenheimer LC, Katz NM, Coughlin SS, Wallace RB: Desmopressin acetate in
cardiac surgery: a double-blind, randomized study. South Med J 1994; 87:611-615
304. Terada
N, Arai Y, Matsuta Y, Maekawa S, Okubo K, Ogura K, Matsuda N, Yonei A: Acute
normovolemic hemodilution for radical prostatectomy: can it replace
preoperative autologous blood transfusion? Int J Urol 2001; 8:149-152
305. Thomas
D, Wareham K, Cohen D, Hutchings H: Autologous blood transfusion in total knee
replacement surgery. Br J Anaesth 2001; 86:669-673
306. Tobias
JD: Synthetic factor VIIa to treat dilutional coagulopathy during posterior
spinal fusion in two children. Anesthesiology 2002; 96:1522-1525
307. Triulzi
DJ, Gilmor GD, Ness PM, Baumgartner WA, Schultheis LW: Efficacy of autologous
fresh whole blood or platelet-rich plasma in adult cardiac surgery. Transfusion
1995; 35:627-634
308. Troianos
CA, Sypula RW, Lucas DM, D'Amico F, Mathie TB, Desai M, Pasqual RT, Pellegrini
RV, Newfeld ML: The effect of prophylactic epsilon-aminocaproic acid on
bleeding, transfusions, platelet function, and fibrinolysis during coronary
artery bypass grafting. Anesthesiology 1999; 91:430-435
309. Trubel
W, Gunen E, Wuppinger G, Tschernko E, Gunen-Frank A, Staudacher M, Polterauer
P: Recovery of intraoperatively shed blood in aortoiliac surgery: comparison of
cell washing with simple filtration. Thorac Cardiovasc Surg 1995; 43:165-170
310. Tsuji
Y, Kambayashi J, Shiba E, Sakon M, Kawasaki T, Mori T: Effect of recombinant
human erythropoietin on anaemia after gastrectomy: a pilot study. Eur J Surg
1995; 161:29-33
311. Uen
WC, Chou YH, Liu CC, Lin SM, Chen TJ: Successful resection of sigmoid colon
cancer in a patient with factor XI deficiency. J Formos Med Assoc 1998;
97:283-285
312. Urban
MK, Beckman J, Gordon M, Urquhart B, Boachie-Adjei O: The efficacy of
antifibrinolytics in the reduction of blood loss during complex adult
reconstructive spine surgery. Spine 2001; 26:1152-1156
313. Veien
M, Sorensen JV, Madsen F, Juelsgaard P: Tranexamic acid given intraoperatively
reduces blood loss after total knee replacement: a randomized, controlled
study. Acta Anaesthesiol Scand 2002; 46:1206-1211
314. Vichinsky
EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M,
Ohene-Frempong K, Iyer RV: A comparison of conservative and aggressive
transfusion regimens in the perioperative management of sickle cell disease.
The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med
1995; 333:206-213
315. Wajon
P, Gibson J, Calcroft R, Hughes C, Thrift B: Intraoperative plateletpheresis
and autologous platelet gel do not reduce chest tube drainage or allogeneic
blood transfusion after reoperative coronary artery bypass graft. Anesth Analg
2001; 93:536-542
316. Walpoth
B, Galliker B, Spirig P, Haeberli A, Rosenmund A, Althaus U, Nydegger UE: Use
of epoetin alfa in autologous blood donation programs for patients scheduled
for elective cardiac surgery. Semin Hematol 1996; 33(2 Suppl 2):75-76
317. Wang
MJ, Chen TL, Huang CH, Chao A, Chu SH: Difference in efficacy of the Cell Saver
in coronary bypass grafting surgery and cardiac valvular reoperations. J Formos
Med Assoc 1994; 93:117-121
318. Waters
JH, Lee JS, Klein E, O'Hara J, Zippe C, Potter PS: Preoperative autologous
donation versus cell salvage in the avoidance of allogeneic transfusion in patients
undergoing radical retropubic prostatectomy. Anesth Analg 2004 ;98:537-542
319. Waters
JH, Lukauskiene E, Anderson ME: Intraoperative blood salvage during cesarean
delivery in a patient with beta thalassemia intermedia. Anesth Analg 2003;
97:1808-1809
320. Waters
JH, Sprung J: Errors during intraoperative cell salvage because of
inappropriate wash solutions. Anesth Analg 2001; 93:1483-1485
321. Weisbach
V, Skoda P, Rippel R, Lauer G, Glaser A, Zingsem J, Zimmermann R, Eckstein R:
Oral or intravenous iron as an adjuvant to autologous blood donation in
elective surgery: a randomized, controlled study. Transfusion 1999; 39:465-472
322. Whitten
CW, Allison PM, Latson TW, Ivy R, Burkhardt D, Gulden RH, Cochran RP:
Evaluation of laboratory coagulation and lytic parameters resulting from
autologous whole blood transfusion during primary aortocoronary artery bypass
grafting. J Clin Anesth 1996; 8:229-235
323. Wilhelmi
M, Franke U, Cohnert T, Weber P, Kaukemuller J, Fischer S, Wahlers T, Haverich
A: Coronary artery bypass grafting surgery without the routine application of
blood products: Is it feasible? Eur J Cardiothorac Surg 2001; 19:657-661
324. Williams
GD, Bratton SL, Riley EC, Ramamoorthy C: Coagulation tests during
cardiopulmonary bypass correlate with blood loss in children undergoing cardiac
surgery. J Cardiothorac Vasc Anesth 1999; 13:398-404
325. Wolowczyk
L, Lewis DR, Nevin M, Smith FC, Baird RN, Lamont PM: The effect of acute
normovolaemic haemodilution on blood transfusion requirements in abdominal
aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001; 22:361-364
326. Wolowczyk
L, Nevin M, Smith FC, Baird RN, Lamont PM: Haemodilutional effect of standard
fluid management limits the effectiveness of acute normovolaemic haemodilution
in AAA surgery--results of a pilot trial. Eur J Vasc Endovasc Surg 2003;
26:405-411
327. Wong
AY, Irwin MG, Hui TW, Fung SK, Fan ST, Ma ES: Desmopressin does not decrease
blood loss and transfusion requirements in patients undergoing hepatectomy. Can
J Anaesth 2002; 50:14-20
328. Wong
JC, Torella F, Haynes SL, Dalrymple K, Mortimer AJ, McCollum CN; ATIS
Investigators: Autologous versus allogeneic transfusion in aortic surgery: a
multicenter randomized clinical trial. Ann Surg 2002; 235:145-151
329. Yamada
T, Yamashita Y, Terai Y, Ueki M: Intraoperative blood salvage in abdominal
uterine myomectomy. Int J Gynaecol Obstet 1997; 56:141-145
330. Yasuda
H, Ohto H, Yamaguchi O, Sakuma S, Suzuki T, Mita M, Tsuneyama H, Uchikawa M:
Three episodes of delayed hemolytic transfusion reactions due to multiple red
cell antibodies, anti-Di, anti-Jk and anti-E. Transfus Sci 2000; 23:107-112
331. Yokomuro
M, Ebine K, Shiroma K, Tamura S, Kumabe S, Ohtuki M, Suzuki H, Uchida S: Safety
and efficacy of autologous platelet transfusion in cardiac surgery: comparison
of cryopreservation, blood collection on the day before surgery, and blood
collection during surgery. Cryobiology 1999; 38:236-242
332. Zabeeda
D, Medalion B, Sverdlov M, Ezra S, Schachner A, Ezri T, Cohen AJ: Tranexamic
acid reduces bleeding and the need for blood transfusion in primary myocardial
revascularization. Ann Thorac Surg 2002; 74:733-738
333. Zupancic Salek S, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M: Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol 2002; 108:162-163